Tag: CPH

Creso Pharma Halucenex Nucro-Technics efficacy synthetic liquid psilocybin treatment-resistant PTSD ASX CPH

Creso Pharma acquisition target Halucenex to test efficacy of synthetic liquid psilocybin for use in treatment-resistant PTSD

Creso Pharma's (ASX: CPH) acquisition target Halucenex Life Sciences Inc has signed an agreement with Canadian pharmaceutical research firm Nucro-Technics to provide microbiology and chemistry test wo...
Creso Pharma Halucenex Life Sciences Sizth Wave Innovations ASX CPH Canada TSX psychedelics

Creso Pharma’s Halucenex makes deal to create pure psilocybin amid softening regulations

As California moves to decriminalise psychedelics, Creso Pharma’s (ASX: CPH) soon-to-be subsidiary Halucenex Life Sciences has signed a letter of intent with Canadian listed Sixth Wave Innovations to ...
Creso Pharma ASX CPH Cannabis Queen South Africa CBD

Creso Pharma signs bilateral deal with South African skincare company to market cannabidoil products

Biotechnology company Creso Pharma (ASX: CPH) has signed a bilateral commercial agreement with South African skincare company Cannabis Queen to market and distribute its range of cannabidoil-based nut...
Creso Pharma ASX CPH Halucenex Life Sciences LSD MDMA Ketamine psychedelic mushrooms Post Traumatic Stress Disorder PTSD mental health

Creso Pharma acquisition target Halucenex joins forces with US biotech to explore the use of magic mushrooms in treating mental illness

Creso Pharma (ASX: CPH) target acquisition company Halucenex Life Sciences Inc has entered into an advisory agreement with US-based biotechnology firm Growing Together Research Inc (GTR) to explore th...
Creso Pharma Mernova Ritual Sticks purchase orders green Canada

Creso Pharma subsidiary Mernova expands in Canada’s recreational cannabis market with more orders

Creso Pharma’s (ASX: CPH) Canadian subsidiary Mernova has collared further purchase orders that include its Ritual Sticks pre-rolled joints and new one-ounce bag offering, which are both part of the w...
Creso Pharma ASX CPH business director US legalisation recreational cannabis John Griese

Creso Pharma appoints new business director ahead of US legalisation for recreational cannabis

Australian company Creso Pharma (ASX: CPH) has appointed leading cannabis executive John Griese to the role of director of US business development, following a global trend towards cannabis legalisati...
Creso Pharma ASX CPH CBD tea cannabis cannaQIX

Creso Pharma launches three CBD-based tea products under cannaQIX brand

As its entry into the psychedelic medicine space progresses, Creso Pharma (ASX: CPH) has continued its cannabinoid product focus with the launch of three CBD-based tea products. The company has unv...
Hallucinogens ASX depression post traumatic stress disorder PTSD psychedelic psychotherapy

With their mind-blowing medical potential, are hallucinogens the next ASX ‘pot stock’ equivalent?

The mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into conniptions. But are these so-called party drugs poised to follow cannabis into the realm of a medi...
Creso Pharma ASX CPH Halucenex generate psychedelic extracts in-house psilocybin mushroom

Creso Pharma’s soon-to-be subsidiary Halucenex executes deal to generate psychedelic extracts in-house

Creso Pharma’s (ASX: CPH) soon to be subsidiary Halucenex Life Sciences will have access to high quality psychedelic extracts for its proposed research via an agreement with medical and recreational e...
Creso Pharma ASX CPH OTCQB OTC Halucenex Life Sciences pharmaceutical grade psilocybin

Creso Pharma eyes OTCQB dual listing, acquisition target Halucenex secures more psilocybin to underpin PTSD trial

Ahead of its upcoming post traumatic stress disorder clinical trials, Creso Pharma’s (ASX: CPH) soon to be subsidiary Canadian psychedelic medicine focused Halucenex Life Sciences has secured pharmace...
Creso Pharma Mernova ASX CPH Canadian subsidiary ritual sticks pre-rolled joints

Creso Pharma’s Canadian subsidiary Mernova continues sales growth after receiving three new purchase orders

Creso Pharma (ASX: CPH) has closed out a busy week with news its wholly-owned Canada-based subsidiary Mernova had received three purchase orders worth a combined $183,019. The purchases include the...
Creso Pharma ASX CPH Halucenex Life Sciences True North Clinical Research PTSD Post Traumatic Stress Disorder psilocybin

Creso Pharma’s acquisition target Halucenex prepares for PTSD trials

Fresh from revealing its proposed acquisition of Canadian psychedelics company Halucenex, Creso Pharma (ASX: CPH) has announced the appointment of a lead investigator for its target’s phase two clinic...
Creso Pharma ASX CPH Halucenex Life Sciences Canadian psychedelic mushrooms PTSD

Creso Pharma makes transformational deal to acquire Canadian psychedelics company Halucenex

Creso Pharma (ASX: CPH) has announced a transformational move to evolve from a medical cannabis company to an integrated natural medicines provider with the acquisition of Canadian psychedelics compan...
Creso Pharma stock ASX CPH Canada recreational cannabis market softening regulatory environment

Creso Pharma expands into Canada’s largest recreational cannabis market amid softening regulatory environment

Medicinal cannabis company Creso Pharma (ASX: CPH) has been riding the wave of loosening regulations relating to cannabis, with company also revealing it has expanded into Canada’s largest recreationa...
Creso Pharma ASX CPH anibidiol dogs Virbac Switzerland

Creso Pharma continues to bask in strong anibidiol sales in Europe

Cannabis and hemp supplier Creso Pharma (ASX: CPH) has updated the market with sales statistics showing that its anibidiol hemp oil products have benefited over 100,000 dogs with the rising “humanisat...
Creso Pharma ASX CPH PharmaCielo cannabis acquisition Colombia

PharmaCielo to acquire Creso Pharma for $122m

Canadian listed company PharmaCielo has launched a takeover bid for Creso Pharma (ASX: CPH), which Creso’s board endorses and values the company at A$122 million. TSXV-listed PharmaCielo has a curr...
Creso Pharma ASX CPH granted license grow medicinal cannabis Canada Mernova facility

Creso Pharma granted licence to grow medicinal cannabis in Canada

The Canadian government has granted Australian company Creso Pharma (ASX: CPH) a licence to cultivate cannabis at a facility run by Creso’s wholly-owned subsidiary Mernova Medical in Nova Scotia. C...
Creso Pharma ASX CPH medical cannabis CBD supply TerrAscend Canada

Creso Pharma signs Canadian medicinal cannabis supply deal

Medicinal cannabis developer Creso Pharma (ASX: CPH) has revealed the latest in a string of deals made since the start of the new year as it continues to build its global enterprise. The company to...
Creso Pharma cannaQIX 50 medical cannabis pain lozenge Brazil launch MedDepot Brasil SIN Solution

Creso Pharma launches medical cannabis pain lozenge in Brazil

Medical cannabis developer Creso Pharma (ASX: CPH) has announced yet another foray into new markets following the launch of its cannaQIX 50 lozenge in South America’s most populous country, Brazil. ...
Creso Pharma ASX CPH cannaQIX Pharmacare Europe UK hemp CBD

Creso Pharma signs UK-focused commercial agreement with Pharmacare Europe

Medical cannabis company Creso Pharma (ASX: CPH) has expanded its UK presence by signing a commercial agreement with UK-based Pharmacare Europe to market and distribute its proprietary cannaQIX produc...
Creso Pharma ASX CPH Middle East Israel medical cannabis

Creso Pharma looks to the Middle East for medical cannabis commerce

Medical cannabis company Creso Pharma (ASX: CPH) has announced further progress on its path of gradual growth and expansion with this morning’s news that it has strengthened its market presence in Isr...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS